[Cost-effectiveness analysis for the treatment of non-erosive reflux disease].

@article{Habu2007CosteffectivenessAF,
  title={[Cost-effectiveness analysis for the treatment of non-erosive reflux disease].},
  author={Yasuki Habu and Yuri Fukui and Takahisa Maruno and Hiroshi Hisatsune and Keiichi Kawai},
  journal={Nihon rinsho. Japanese journal of clinical medicine},
  year={2007},
  volume={65 5},
  pages={951-5}
}
Non-erosive reflux disease(NERD) is a common condition and acid-suppressing agents are the mainstay of treatment. A cost-effectiveness analysis comparing a PPI, lansoprazole (LPZ) and a H2RA, ranitidine (RAN) for the treatment of NERD in Japan was performed using a decision analysis. The time period studied was one month and payer or patient' s perspective… CONTINUE READING